Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment
- 1 April 1986
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 111 (4) , 644-648
- https://doi.org/10.1016/0002-8703(86)90092-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Amiodarone: Correlation of serum concentration with suppression of complex ventricular ectopic activityThe American Journal of Cardiology, 1984
- Amiodarone: Intravenous loading for rapid suppression of complex ventricular arrhythmiasJournal of the American College of Cardiology, 1984
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- High-Performance Liquid Chromatographic Measurement of Amiodarone and Its Desethyl MetaboliteTherapeutic Drug Monitoring, 1982
- Identification and measurement of desethylamiodarone in blood plasma specimens from amiodarone-treated patientsJournal of Pharmacy and Pharmacology, 1982
- Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.Circulation, 1982
- Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones.Journal of Clinical Investigation, 1976
- The effect of amiodarone, a new anti‐anginal drug, on cardiac muscleBritish Journal of Pharmacology, 1970